Type 2 Diabetes Genetic Variants and Risk of Diabetic Retinopathy

Ophthalmology

Volumn 124, Issue 3, 2017, Pages 336-342

  Chong, Yong He ^a,b   Fan, Qiao ^b   Tham, Yih Chung ^a   Gan, Alfred ^a   Tan, Shu Pei ^a   Tan, Gavin ^a   Wang, Jie Jin ^c   Mitchell, Paul ^c   Wong, Tien Yin ^a,b,d   Cheng, Ching Yu ^a,b,d  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c UNIVERSITY OF SYDNEY   (Australia)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN A1C;

ADULT; AGED; ALLELE; AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; EYE EXAMINATION; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC ASSOCIATION STUDY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH ASIAN; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; ODDS RATIO; SINGAPORE;

AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SINGAPORE;

EID: 85009275319     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2016.11.016     Document Type: Article

References (45)

1. 1 Fowler, M.J., Microvascular and macrovascular complications of diabetes. Clin Diabetes 29:3 (2011), 116–122.
2. 2 Cheung, N., Mitchell, P., Wong, T.Y., Diabetic retinopathy. Lancet 376 (2010), 124–136.
3. 3 Yau, J.W.Y., Rogers, S.L., Kawasaki, R., et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:3 (2012), 556–564.
4. 4 Bourne, R.R., Stevens, G.A., White, R.A., et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health 1:6 (2013), e339–349.
5. 5 Stratton, I.M., Kohner, E.M., Aldington, S.J., et al. UKPDS 50L risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44 (2001), 156–163.
6. 6 Klein, R., Klein, B.E., Moss, S.E., Cruickshanks, K.J., Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 154 (1994), 2169–2178.
7. 7 Romero-Aroca, P., Baget-Bernaldiz, M., Fernandez-Ballart, J., et al. Ten-year incidence of diabetic retinopathy and macular edema. Risk factors in a sample of people with type 1 diabetes. Diabetes Res Clin Pract 94:1 (2011), 126–132.
8. 8 Xu, J., Xu, L., Wang, Y.X., et al. Ten-year cumulative incidence of diabetic retinopathy. The Beijing Eye Study 2001/2011. PLoS One, 9(10), 2014, e111320.
9. 9 Ding, J., Wong, T.Y., Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep 12:4 (2012), 346–354.
10. 10 Liew, G., Klein, R., Wong, T.Y., The role of genetics in susceptibility to diabetic retinopathy. Int Ophthalmol Clin 49:2 (2009), 35–52.
11. 11 Wong, T.Y., Klein, R., Islam, A., et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 141:3 (2006), 446–455.
12. 12 Arar, N.H., Freedman, B.I., Adler, S.G., et al. Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci 49:9 (2008), 3839–3845.
13. 13 Hietala, K., Forsblom, C., Summanen, P., et al. Heritability of proliferative diabetic retinopathy. Diabetes 57:8 (2008), 2176–2180.
14. 14 Uhlmann, K., Kovacs, P., Boettcher, Y., et al. Genetics of diabetic retinopathy. Exp Clin Endocrinol Diabetes 114:6 (2006), 275–294.
15. 15 Abhary, S., Hewitt, A.W., Burdon, K.P., Craig, J.E., A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes 58:9 (2009), 2137–2147.
16. 16 Fu, Y.P., Hallman, D.M., Gonzalez, V.H., et al. Identification of diabetic retinopathy genes through a genome-wide association study among Mexican-Americans from Starr County, Texas. J Ophthalmol, 2010, 2010.
17. 17 Awata, T., Yamashita, H., Kurihara, S., et al. A genome-wide association study for diabetic retinopathy in a Japanese population: potential association with a long intergenic non-coding RNA. PLoS One, 9(11), 2014, e111715.
18. 18 Sheu, W.H., Kuo, J.Z., Lee, I.T., et al. Genome-wide association study in a Chinese population with diabetic retinopathy. Hum Mol Genet 22:15 (2013), 3165–3173.
19. 19 Huang, Y.C., Lin, J.M., Lin, H.J., et al. Genome-wide association study of diabetic retinopathy in a Taiwanese population. Ophthalmology 118:4 (2011), 642–648.
20. 20 Grassi, M.A., Tikhomirov, A., Ramalingam, S., et al. Genome-wide meta-analysis for severe diabetic retinopathy. Hum Mol Genet 20:12 (2011), 2472–2481.
21. 21 Peng, D., Wang, J., Zhang, R., et al. Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetologia 58:6 (2015), 1231–1238.
22. 22 Simoes, M.J., Lobo, C., Egas, C., et al. Genetic variants in ICAM1, PPARGC1A and MTHFR are potentially associated with different phenotypes of diabetic retinopathy. Ophthalmologica 232:3 (2014), 156–162.
23. 23 Dorajoo, R., Liu, J., Boehm, B.O., Genetics of type 2 diabetes and clinical utility. Genes (Basel) 6:2 (2015), 372–384.
24. 24 Mahajan, A., Go, M.J., Zhang, W., et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 46:3 (2014), 234–244.
25. 25 Saxena, R., Saleheen, D., Been, L.F., et al. Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India. Diabetes 62 (2013), 1746–1755.
26. 26 Hara, K., Fujita, H., Johnson, T.A., et al. Genome-wide association study identifies three novel loci for type 2 diabetes. Hum Mol Genet 23:1 (2014), 239–246.
27. 27 Ma, R.C., Hu, C., Tam, C.H., et al. Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. Diabetologia 56:6 (2013), 1291–1305.
28. 28 Williams, A.L., Jacobs, S.B.R., Moreno-Macías, H., et al. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 506:7486 (2013), 97–101.
29. 29 Go, M.J., Hwang, J.Y., Park, T.J., et al. Genome-wide association study identifies two novel Loci with sex-specific effects for type 2 diabetes mellitus and glycemic traits in a Korean population. Diabetes Metab J 38:5 (2014), 375–387.
30. 30 Melzer, D., Murray, A., Hurst, A.J., et al. Effects of the diabetes linked TCF7L2 polymorphism in a representative older population. BMC Med, 4, 2006, 34.
31. 31 Malecki, M.T., Cyganek, K., Mirkiewicz-Sieradzka, B., et al. Alanine variant of the Pro12Ala polymorphism of the PPARγ gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes. Diabetes Res Clin Pract 80:1 (2008), 139–145.
32. 32 Liu, N.J., Wu, H.H., Li, Y.L., et al. An analysis of the association between a polymorphism of KCNJ11 and diabetic retinopathy in a Chinese Han population. Eur J Med Res, 20, 2015, 3.
33. 33 Foong, A.W., Saw, S.M., Loo, J.L., et al. Rationale and methodology for a population-based study of eye diseases in Malay people: the Singapore Malay eye study (SiMES). Ophthalmic Epidemiol 14:1 (2007), 25–35.
34. 34 Lavanya, R., Jeganathan, V.S., Zheng, Y., et al. Methodology of the Singapore Indian Chinese Cohort (SICC) eye study: quantifying ethnic variations in the epidemiology of eye diseases in Asians. Ophthalmic Epidemiol 16:6 (2009), 325–336.
35. 35 Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs–an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98:5 Suppl (1991), 786–806.
36. 36 Fan, Q., Barathi, V.A., Cheng, C.Y., et al. Genetic variants on chromosome 1q41 influence ocular axial length and high myopia. PLoS Genet, 8(6), 2012, e1002753.
37. 37 Li, Y., Willer, C.J., Ding, J., et al. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34 (2010), 816–834.
38. 38 Price, A.L., Patterson, N., Plenge, R.M., et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38 (2006), 904–909.
39. 39 Chua, J., Tham, Y.C., Liao, J., et al. Ethnic differences of intraocular pressure and central corneal thickness: the Singapore Epidemiology of Eye Diseases study. Ophthalmology 121:10 (2014), 2013–2022.
40. 40 Tham, Y.C., Liao, J., Vithana, E.N., et al. Aggregate effects of intraocular pressure and cup-to-disc ratio genetic variants on glaucoma in a multiethnic Asian population. Ophthalmology 122:6 (2015), 1149–1157.
41. 41 Ting, D.S., Cheung, G.C., Wong, T.Y., Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Experiment Ophthalmol 44:4 (2016), 260–277.
42. 42 Kovarik, J.J., Eller, A.W., Willard, L.A., et al. Prevalence of undiagnosed diabetic retinopathy among inpatients with diabetes: the diabetic retinopathy inpatient study (DRIPS). BMJ Open Diabetes Res Care, 4(1), 2016, e000164.
43. 43 Huang, O.S., Tay, W.T., Ong, P.G., et al. Prevalence and determinants of undiagnosed diabetic retinopathy and vision-threatening retinopathy in a multiethnic Asian cohort: the Singapore Epidemiology of Eye Diseases (SEED) study. Br J Ophthalmol 99:12 (2015), 1614–1621.
44. 44 UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:7160 (1998), 703–713.
45. 45 The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:14 (1993), 977–986.